Replimune Group, Inc. (REPL)
9.89
+0.07
(+0.71%)
USD |
NASDAQ |
Dec 31, 11:21
Replimune Group Market Cap: 775.80M for Dec. 31, 2025
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rapt Therapeutics, Inc. | 557.49M |
| Olema Pharmaceuticals, Inc. | 1.745B |
| CorMedix, Inc. | 955.71M |
| Verastem, Inc. | 566.40M |
| Anavex Life Sciences Corp. | 321.65M |
Market Cap Related Metrics
| PEG Ratio | -0.1739 |
| Price to Book Value | 2.946 |
| Price | 9.89 |
| Earnings Yield | -36.48% |
| PEGY Ratio | -0.1739 |